𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cryptococcus neoformans infection in ulcerative colitis with immunosuppressants

✍ Scribed by Li-Ping Chen; Jin Li; Mei-Fang Huang; Qing-Song Chen; Bing Xia

Book ID
102268183
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
108 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

✦ Synopsis

To the Editor:

The etiology of ulcerative colitis (UC) remains unclear. As effective drugs for induction of remission and maintenance therapy for the disease, immunomodulators are often used in UC patients. Cryptococcus neoformans infection in UC patients using immunomodulators occurs rarely; herein we reported two cases and reviewed the relevant literature.

πŸ“œ SIMILAR VOLUMES

Experiences with immunosuppressive thera
Experiences with immunosuppressive therapy in childhood ulcerative colitis
✍ SchοΏ½fer, K. -H. ;BlοΏ½ker, F. πŸ“‚ Article πŸ“… 1971 πŸ› Springer-Verlag βš– 556 KB

Since 1966 we treated 22 patients with ulcerative colitis, 15 of which with severe diseases were selected for immunosuppressive therapy according to strictly defined criteria. Difficulties were observed in 2 eases. In 13 cases immunosuppressive therapy promptly resulted in clinical and reetoseopic r

Factors affecting experimental infection
Factors affecting experimental infection with Cryptococcus neoformans in mice with special reference to an endotoxic substance of C. neoformans
✍ Takashi Kobayashi; Osamu Kato; Izumi Nakashima; Nobuo Kato πŸ“‚ Article πŸ“… 1975 πŸ› Springer Netherlands 🌐 English βš– 412 KB

A close correlation was observed between body weight and length of the survival time of mice inoculated intravenously (i.v.)with Cryptococeus neoformans (p < 0.001). An endotoxic substance of C. neoformans (Cr-ET) increased the susceptibility of mice to i.v. infection of C. neoformans only when more